Clinical Trial Update: Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain [Phase 4]

View source ↗

Summary

Phase 4 trial update on patient-controlled intrathecal analgesia using bupivacaine for chronic low back pain; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Bupivacaine (Bupivacaine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Pain, Intractable, Breakthrough Pain | Phase 4 | Status: COMPLETED | Results posted: 2022-03-24